Functional and morphological myocardial changes in hepatitis C virus patients with end-stage liver disease

References

• EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011;55:245–64.
   PubMed Web of Science ®Google Scholar
• Strickland GT, Elhefni H, Salman T, Waked I, Abdel Hamid M, Mikhail NN, et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002;67:436–42.
   PubMed Web of Science ®Google Scholar
• Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009;16:650–8.
   PubMed Web of Science ®Google Scholar
• Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2014;11:177–86.
   PubMed Web of Science ®Google Scholar
• Snowden CP, Hughes T, Rose J, Roberts DR. Pulmonary edema in patients after liver transplantation. Liver Transpl 2000;6:466–70.
   Google Scholar
• Torregrosa M, Aguade S, Dos L, Segura R, Gónzalez A, Evangelista A, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005;42:68–74.
   PubMed Web of Science ®Google Scholar
• Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS, Bain VG, et al. Prediction of cardiac complications after liver transplantation. Transplantation 2009;87:763–70.
   Google Scholar
• Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 2006;12:293–8.
   PubMed Web of Science ®Google Scholar
• Forde KA, Haynes K, Troxel AB, Trooskin S, Osterman MT, Kimmel SE, et al. Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study. Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study. J Viral Hepat 2012;19:271–7.
   Google Scholar
• Oliveira CP, Kappel CR, Siqueira ER, Lima VM, Stefano JT, Michalczuk MT, et al. Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol 2013;164:221–6.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther 2013;37:647–52.
   PubMed Web of Science ®Google Scholar
• Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940–65.
   PubMed Web of Science ®Google Scholar
• Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218–23.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Bierig M, Devereux RB, Flachskampf FA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107–33.
   PubMed Web of Science ®Google Scholar
• Cerqueira MD, Weissman NJ, Dilsizian VJacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation 2002;105:539–42.
   PubMed Web of Science ®Google Scholar
• Baron N, Kachenoura N, Cluzel P, Frouin F, Herment A, Grenier P, et al. Comparison of various methods for quantitative evaluation of myocardial infarct volume from magnetic resonance delayed enhancement data. Int J Cardiol 2013;167:739–44.
   Google Scholar
• Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010;59:105–10.
   PubMed Web of Science ®Google Scholar
• Liu H, Gaskari SA, Lee SS. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol 2006;12:837–42.
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen J H. Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy. Scand J Gastroenterol 2001;36:785–94.
   PubMed Web of Science ®Google Scholar
• Liu H, Lee SS. Cardiopulmonary dysfunction in cirrhosis. J Gastroenterol Hepatol 1999;14:600–8.
   PubMedGoogle Scholar
• Pateron D, Beyne P, Laperche T, Logeard D, Lefilliatre P, Sogni P, et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999;29:640–3.
   PubMed Web of Science ®Google Scholar
• Lossnitzer D, Steen H, Zahn A, Lehrke S, Weiss C, Weiss KH, et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis. J Cardiovasc Magn Reson 2010;12:47.
   Google Scholar
• Wang L, Zhou Z, Saari JT, Kang YJ. Alcohol-induced myocardial fibrosis in metallothionein-null mice: prevention by zinc supplementation. Am J Pathol 2005;167:337–44.
   Google Scholar
• Fernandez-Sola J, Estruch R, Grau JM, Pare JC, Rubin E, Urbano-Marquez A. The relation of alcoholic myopathy to cardiomyopathy. Ann Intern Med 1994;120:529–36.
   PubMed Web of Science ®Google Scholar
• Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F, et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2009;2:437–43.
   PubMed Web of Science ®Google Scholar
• Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006;43:s121–31.
   PubMed Web of Science ®Google Scholar
• Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005;42:439–47.
   PubMed Web of Science ®Google Scholar
• Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007;56:869–75.
   PubMed Web of Science ®Google Scholar
• Ruiz-del-Arbol L, Achécar L, Serradilla R, Rodríguez-Gandía MÁ, Rivero M, Garrido E, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension and a normal creatinine. Hepatology 2013;58:1732–41.
   PubMed Web of Science ®Google Scholar
• Nazar A, Guevara M, Sitges M, Terra C, Solà E, Guigou C, et al. Left ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol 2013;58:51–7.
   PubMed Web of Science ®Google Scholar
• Choi1 EY, Choi BW, Kim SA, Rhee SJ, Shim CY, Kim YJ, et al. Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2009;11:573–80.
   Google Scholar
• Choong CY, Herrmann HC, Weyman AE, Fifer MA. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol 1987;10:800–8.
   PubMed Web of Science ®Google Scholar
• Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997;26:1131–7.
   PubMed Web of Science ®Google Scholar
• Abd-El-Aziz TA, Abdou M, Fathy A, Wafaie M. Evaluation of cardiac function in patients with liver cirrhosis. Intern Med 2010;49:2547–52.
   Google Scholar
• Finucci G, Desideri A, Sacerdoti D, Bolognesi M, Merkel C, Angeli P, et al. Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996;31:279–84.
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen J. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002;87:9–15.
   PubMed Web of Science ®Google Scholar
• Hudsmith LE, Petersen SE, Tyler DJ, Francis JM, Cheng AS, Clarke K, et al. Determination of cardiac volumes and mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: a validation study. J Magn Reson Imaging 2006;24:312–18.
   PubMed Web of Science ®Google Scholar